Eli Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Eli Lilly and
LLY Stock  USD 1,010  13.70  1.34%   
Eli Lilly's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Eli Lilly's valuation are provided below:
Gross Profit
54.1 B
Profit Margin
0.3167
Market Capitalization
952.3 B
Enterprise Value Revenue
15.35
Revenue
65.2 B
We have found one hundred twenty available fundamental signals for Eli Lilly and, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Eli Lilly and prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 495.4 B in 2026. Enterprise Value is likely to rise to about 516.6 B in 2026

Eli Lilly Total Revenue

68.44 Billion

Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 974.3 M, Interest Expense of 835.1 M or Total Revenue of 68.4 B, as well as many indicators such as Price To Sales Ratio of 15.55, Dividend Yield of 0.0053 or PTB Ratio of 38.19. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
Build AI portfolio with Eli Stock
Check out the analysis of Eli Lilly Correlation against competitors.

Eli Lilly Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets118.1 B112.5 B50.8 B
Slightly volatile
Short and Long Term Debt Total44.6 B42.5 B16.6 B
Slightly volatile
Other Current Liabilities23.5 B22.3 B10.8 B
Slightly volatile
Total Current Liabilities37 B35.2 B15.8 B
Slightly volatile
Total Stockholder Equity27.9 B26.5 B13 B
Slightly volatile
Property Plant And Equipment Net25.9 B24.7 B10.8 B
Slightly volatile
Retained Earnings25.7 B24.5 B13.5 B
Pretty Stable
Cash7.5 B7.2 B4.3 B
Slightly volatile
Non Current Assets Total59.7 B56.8 B29.6 B
Slightly volatile
Non Currrent Assets Other7.3 B7 B3.9 B
Slightly volatile
Cash And Short Term Investments3.8 B7.3 B4.6 B
Pretty Stable
Net Receivables21.2 B20.2 B7.7 B
Slightly volatile
Common Stock Shares Outstanding867.6 M898 M1 B
Slightly volatile
Liabilities And Stockholders Equity118.1 B112.5 B50.8 B
Slightly volatile
Non Current Liabilities Total53.2 B50.7 B22 B
Slightly volatile
Inventory14.4 B13.7 B4.9 B
Slightly volatile
Other Current Assets15.2 B14.5 B3.7 B
Slightly volatile
Total Liabilities90.2 B85.9 B37.7 B
Slightly volatile
Total Current Assets58.4 B55.6 B21.3 B
Slightly volatile
Intangible Assets6.8 B6.5 B4.9 B
Slightly volatile
Short Term Debt1.4 B1.6 B1.9 B
Slightly volatile
Accounts Payable5.6 B5.4 B2 B
Slightly volatile
Property Plant And Equipment Gross39.1 B37.2 B15 B
Slightly volatile
Short Term Investments99.8 M105 M585.6 M
Slightly volatile
Capital Stock539.3 M590 M644 M
Slightly volatile
Common Stock539.3 M590 M644 M
Slightly volatile
Other Liabilities5.5 B7 B6.7 B
Slightly volatile
Long Term Debt42.9 B40.9 B14.8 B
Slightly volatile
Property Plant Equipment27.2 B25.9 B11.1 B
Slightly volatile
Good Will3.3 B5.9 B3.3 B
Slightly volatile
Current Deferred Revenue17.5 B16.7 B8.1 B
Slightly volatile
Long Term Debt Total42.9 B40.9 B15.2 B
Slightly volatile
Capital Surpluse6.9 B7.3 B6.2 B
Slightly volatile
Long Term Investments2.8 B2.8 B3.7 B
Slightly volatile
Non Current Liabilities Other4.1 B4 B5.1 B
Slightly volatile
Short and Long Term Debt2.3 B1.6 B1.7 B
Slightly volatile
Cash And Equivalents7.6 B7.3 B4.6 B
Very volatile
Net Invested Capital35.9 B69 B29.8 B
Slightly volatile
Capital Lease Obligations389.4 M438 M478.1 M
Slightly volatile

Eli Lilly Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization974.3 M1.6 B1.4 B
Slightly volatile
Total Revenue68.4 B65.2 B28.9 B
Slightly volatile
Gross Profit57.3 B54.6 B22.9 B
Slightly volatile
Other Operating Expenses37.3 B35.5 B19.7 B
Slightly volatile
Operating Income31.2 B29.7 B9.3 B
Slightly volatile
EBIT27.7 B26.4 B8 B
Slightly volatile
EBITDA29.3 B27.9 B9.4 B
Slightly volatile
Cost Of Revenue11.1 B10.6 B6 B
Slightly volatile
Total Operating Expenses26.2 B24.9 B13.7 B
Slightly volatile
Income Before Tax27 B25.7 B7.6 B
Slightly volatile
Income Tax Expense5.3 B5.1 B1.5 B
Slightly volatile
Selling General Administrative5.9 B11.1 B6.6 B
Slightly volatile
Research Development14 B13.3 B6.8 B
Slightly volatile
Non Recurring267.2 M281.3 M664.5 M
Pretty Stable
Selling And Marketing Expenses394.9 M415.7 M3.4 B
Slightly volatile
Minority Interest241.8 M211.1 M163.9 M
Slightly volatile
Tax Provision5.3 B5.1 B1.3 B
Slightly volatile
Interest Income674.1 M642 M208.1 M
Slightly volatile
Reconciled Depreciation1.7 B2 B1.6 B
Slightly volatile

Eli Lilly Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.4 B3.3 B4 B
Pretty Stable
Depreciation1.1 B2 B1.4 B
Slightly volatile
Capital Expenditures8.2 B7.8 B3.1 B
Slightly volatile
Total Cash From Operating Activities17.7 B16.8 B6.8 B
Slightly volatile
End Period Cash Flow7.6 B7.3 B4.3 B
Slightly volatile
Issuance Of Capital Stock1.3 B1.5 B1.6 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.5514.80647.438
Slightly volatile
Dividend Yield0.00530.00560.0209
Slightly volatile
PTB Ratio38.1936.369521.2773
Slightly volatile
Days Sales Outstanding63.6611388.3119
Slightly volatile
Book Value Per Share31.0329.548913.1122
Slightly volatile
Operating Cash Flow Per Share19.6618.72277.0232
Slightly volatile
Stock Based Compensation To Revenue0.00940.00960.0113
Slightly volatile
Capex To Depreciation4.123.92642.0526
Slightly volatile
PB Ratio38.1936.369521.2773
Slightly volatile
EV To Sales16.1215.34867.7818
Slightly volatile
Inventory Turnover0.730.76861.4516
Slightly volatile
Days Of Inventory On Hand499475274
Slightly volatile
Payables Turnover1.871.96393.6063
Slightly volatile
Sales General And Administrative To Revenue0.30.17020.2707
Slightly volatile
Research And Ddevelopement To Revenue0.170.20460.2312
Pretty Stable
Capex To Revenue0.10.12030.0999
Slightly volatile
Cash Per Share8.58.09354.7957
Pretty Stable
POCF Ratio60.2757.399935.3959
Slightly volatile
Interest Coverage27.9737.339424.9845
Very volatile
Capex To Operating Cash Flow0.340.46640.4689
Slightly volatile
Days Payables Outstanding131186106
Slightly volatile
EV To Operating Cash Flow62.4859.501937.0187
Slightly volatile
Intangibles To Total Assets0.130.11040.166
Pretty Stable
Current Ratio1.61.57911.3887
Slightly volatile
Receivables Turnover5.33.23394.3182
Slightly volatile
Graham Number13012442.5962
Slightly volatile
Shareholders Equity Per Share31.0329.548912.993
Slightly volatile
Debt To Equity1.681.60181.513
Slightly volatile
Capex Per Share9.178.73163.3501
Slightly volatile
Revenue Per Share76.2172.582229.7367
Slightly volatile
Interest Debt Per Share50.6348.216317.6457
Slightly volatile
Debt To Assets0.40.37790.2858
Slightly volatile
Enterprise Value Over EBITDA36.9435.8125.5319
Slightly volatile
Short Term Coverage Ratios9.7710.283274.0962
Very volatile
Operating Cycle617588366
Slightly volatile
Price Book Value Ratio38.1936.369521.2773
Slightly volatile
Days Of Payables Outstanding131186106
Slightly volatile
Price To Operating Cash Flows Ratio60.2757.399935.3959
Slightly volatile
Pretax Profit Margin0.260.39480.2242
Slightly volatile
Ebt Per Ebit0.980.86640.8443
Slightly volatile
Operating Profit Margin0.480.45560.2804
Slightly volatile
Effective Tax Rate0.250.19790.2322
Pretty Stable
Company Equity Multiplier2.564.23884.4763
Slightly volatile
Long Term Debt To Capitalization0.640.60630.4774
Slightly volatile
Total Debt To Capitalization0.310.61560.4881
Slightly volatile
Return On Capital Employed0.280.38440.2289
Slightly volatile
Debt Equity Ratio1.681.60181.513
Slightly volatile
Ebit Per Revenue0.480.45560.2804
Slightly volatile
Quick Ratio1.241.1891.0682
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.491.27131.254
Slightly volatile
Cash Ratio0.190.20330.3359
Slightly volatile
Cash Conversion Cycle422402260
Slightly volatile
Operating Cash Flow Sales Ratio0.280.2580.2374
Pretty Stable
Days Of Inventory Outstanding499475274
Slightly volatile
Days Of Sales Outstanding63.6611388.3119
Slightly volatile
Cash Flow Coverage Ratios0.380.39560.6355
Slightly volatile
Price To Book Ratio38.1936.369521.2773
Slightly volatile
Fixed Asset Turnover1.842.64152.6464
Pretty Stable
Capital Expenditure Coverage Ratio3.722.14422.9722
Slightly volatile
Price Cash Flow Ratio60.2757.399935.3959
Slightly volatile
Enterprise Value Multiple36.9435.8125.5319
Slightly volatile
Debt Ratio0.40.37790.2858
Slightly volatile
Cash Flow To Debt Ratio0.380.39560.6355
Slightly volatile
Price Sales Ratio15.5514.80647.438
Slightly volatile
Asset Turnover0.70.57950.5929
Slightly volatile
Gross Profit Margin0.620.83790.7632
Very volatile
Price Fair Value38.1936.369521.2773
Slightly volatile

Eli Lilly Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap495.4 B471.8 B320.3 B
Slightly volatile
Enterprise Value516.6 B492 B510 B
Slightly volatile

Eli Fundamental Market Drivers

Forward Price Earnings27.1739
Cash And Short Term Investments7.3 B

Eli Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue16.7 B17.5 B
Total Revenue65.2 B68.4 B
Cost Of Revenue10.6 B11.1 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.17  0.30 
Research And Ddevelopement To Revenue 0.20  0.17 
Capex To Revenue 0.12  0.10 
Revenue Per Share 72.58  76.21 
Ebit Per Revenue 0.46  0.48 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY